Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131862) titled 'Predicting Myelosuppression Risk after Chemotherapy in Gynecological Cancer Patients' on Sept. 7.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Peking Union Medical College Hospital
Condition:
ovarian cancer, cervical cancer, or endometrial cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-09
Target Sample Size: Total Cohort:15000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=341599
Published by HT Digital Content Services with permission from Health Daily Digest....